Evidence map›Paper›PMID 35439054›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

An epilepsy-associated K

Michelle Nilsson, Sarah H Lindström, Maki Kaneko, Kaiqian Wang, Teresa Minguez-Viñas, Marina Angelini, Federica Steccanella, Deborah Holder, Michela Ottolia, Riccardo Olcese and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Competitive modulation of KFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  5. Targeting heterozygous dominant negative variant ofMolecular therapy. Nucleic acids · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Editorial: The synaptic basis of neuropathology.Frontiers in synaptic neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michelle NilssonDivision of Neurobiology, Department of Biomedical and Clinical Sciences (BKV), Linköping University, 581 83 Linköping, Sweden.ORCID 0000-0002-0891-7732
Sarah H LindströmDivision of Neurobiology, Department of Biomedical and Clinical Sciences (BKV), Linköping University, 581 83 Linköping, Sweden.ORCID 0000-0001-7952-8120
Maki KanekoCenter for Personalized Medicine, Children's Hospital Los Angeles, Los Angeles, CA 90027.ORCID 0000-0002-2489-6185
Kaiqian WangDivision of Neurobiology, Department of Biomedical and Clinical Sciences (BKV), Linköping University, 581 83 Linköping, Sweden.
Teresa Minguez-ViñasDivision of Neurobiology, Department of Biomedical and Clinical Sciences (BKV), Linköping University, 581 83 Linköping, Sweden.
Marina AngeliniDivision of Molecular Medicine, Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.ORCID 0000-0003-4621-3784
Federica SteccanellaDivision of Molecular Medicine, Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
Deborah HolderComprehensive Epilepsy Program, Children's Hospital Los Angeles, Los Angeles, CA 90027.ORCID 0000-0001-5532-4764
Michela OttoliaDivision of Molecular Medicine, Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
Riccardo OlceseDivision of Molecular Medicine, Department of Anesthesiology & Perioperative Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.
Antonios PantazisDivision of Neurobiology, Department of Biomedical and Clinical Sciences (BKV), Linköping University, 581 83 Linköping, Sweden.ORCID 0000-0002-6467-1327

Funding

REGULATION OF ION CHANNELS BY METHIONINE OXIDATIONR01GM057654 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI HOSHI, TOSHINORI, OLCESE, RICCARDO · 1998 to 2014
$5.0M
Sodium Dependent Inactivation of the Na+-Ca2+ exchange: Relevance to Cardiac FunctionR01HL152296 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OLCESE, RICCARDO, OTTOLIA, MICHELA · 2021 to 2024
$2.2M
The Molecular Transitions that Initiate EC Coupling in Skeletal MuscleR35GM131896 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OLCESE, RICCARDO · 2019 to 2023
$2.0M
NHLBI NIH HHS R01 HL152296NIGMS NIH HHS R01 GM057654NIGMS NIH HHS R35 GM131896
6 · The paper itself

Abstract

We report on a heterozygous KCNA2 variant in a child with epilepsy. KCNA2 encodes KV1.2 subunits, which form homotetrameric potassium channels and participate in heterotetrameric channel complexes with other KV1-family subunits, regulating neuronal excitability. The mutation causes substitution F233S at the KV1.2 charge transfer center of the voltage-sensing domain. Immunocytochemical trafficking assays showed that KV1.2(F233S) subunits are trafficking deficient and reduce the surface expression of wild-type KV1.2 and KV1.4: a dominant-negative phenotype extending beyond KCNA2, likely profoundly perturbing electrical signaling. Yet some KV1.2(F233S) trafficking was rescued by wild-type KV1.2 and KV1.4 subunits, likely in permissible heterotetrameric stoichiometries: electrophysiological studies utilizing applied transcriptomics and concatemer constructs support that up to one or two KV1.2(F233S) subunits can participate in trafficking-capable heterotetramers with wild-type KV1.2 or KV1.4, respectively, and that both early and late events along the biosynthesis and secretion pathway impair trafficking. These studies suggested that F233S causes a depolarizing shift of ∼48 mV on KV1.2 voltage dependence. Optical tracking of the KV1.2(F233S) voltage-sensing domain (rescued by wild-type KV1.2 or KV1.4) revealed that it operates with modestly perturbed voltage dependence and retains pore coupling, evidenced by off-charge immobilization. The equivalent mutation in the Shaker K+ channel (F290S) was reported to modestly affect trafficking and strongly affect function: an ∼80-mV depolarizing shift, disrupted voltage sensor activation and pore coupling. Our work exposes the multigenic, molecular etiology of a variant associated with epilepsy and reveals that charge-transfer-center disruption has different effects in KV1.2 and Shaker, the archetypes for potassium channel structure and function.

Indexed as

EpilepsyCell MembraneChildHumansKv1.1 Potassium ChannelKv1.2 Potassium ChannelMutationPotassiumPotassium ChannelsKv1.1 Potassium ChannelKv1.2 Potassium ChannelPotassiumPotassium Channelschannelopathydominant negativefluorometryion channeltrafficking

Identifiers

PMID35439054
PMCPMC9169947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.